Skip to main content
Top

Journal of Inherited Metabolic Disease

Issue 2/2004

Content (25 Articles)

Executive function impairment in early-treated PKU subjects with normal mental development

V. Leuzzi, M. Pansini, E. Sechi, F. Chiarotti, Cl. Carducci, G. Levi, I. Antonozzi

A new, low-volume protein substitute for teenagers and adults with phenylketonuria

A. MacDonald, M. Lilburn, B. Cochrane, P. Davies, A. Daly, D. Asplin, S. K. Hall, A. Cousins, A. Chakrapani, P. Robinson, P. Lee

Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria

G. L. Arnold, C. J. Vladutiu, C. C. Orlowski, E. M. Blakely, J. DeLuca

The Resource Mothers Study of Maternal Phenylketonuria: Preliminary findings

F. Rohr, A. Munier, D. Sullivan, I. Bailey, M. Gennaccaro, H. Levy, H. Brereton, S. Gleason, B. Goss, E. Lesperance, K. Moseley, R. Singh, L. Tonyes, H. Vespa, S. Waisbren

Discordant PKU phenotype in one family due to disparate genotypes and a novel mutation

J. J. Johnston, U. Lichter-Konecki, E. Wilson, B. R. Cobb, B. M. Evans, R. E. Schnur, L -J. C. Wong

How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency?

S. Grünewald, L. Fairbanks, S. Genet, T. Cranston, J. Hüsing, J. V. Leonard, M. P. Champion

Low-protein diet and progression of retinal degeneration in gyrate atrophy of the choroid and retina: A twenty-six-year follow-up

R. Santinelli, C. Costagliola, C. Tolone, A. D'Aloia, A. D'Avanzo, F. Prisco, L. Perrone, E. Miraglia del Giudice

Maternal histidinaemia: Pregnancies and offspring outcomes

H. L. Levy, J. J. Yu, S. E. Waisbren

Living-donor liver transplantation for propionic acidaemia

T. Yorifuji, M. Kawai, M. Mamada, K. Kurokawa, H. Egawa, Y. Shigematsu, Y. Kohno, K. Tanaka, T. Nakahata

Intrastriatal malonate administration induces convulsive behaviour in rats

J. Fleck, M. C. P. Ribeiro, C. M. Schneider, V. D. G. Sinhorin, M. A. Rubin, C. F. Mello

CNS involvement in Fabry disease: Clinical and imaging studies before and after 12 months of enzyme replacement therapy

L. Jardim, L. Vedolin, I. V. D. Schwartz, M. G. Burin, C. Cecchin, L. Kalakun, U. Matte, F. Aesse, C. Pitta-Pinheiro, J. Marconato, R. Giugliani

Juvenile Sandhoff disease—Nine new cases and a review of the literature

C. J. Hendriksz, P. C. Corry, J. E. Wraith, G. T. N. Besley, A. Cooper, C. D. Ferrie

Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies

E. Rocchi, P. Ventura, A. Ronzoni, M. C. Rosa, C. Gozzi, L. Marri, G. Casalgrandi, M. D. Cappellini

Glutathione synthetase deficiency associated with antenatal cerebral bleeding

L. W. Brüggemann, F. Groenendaal, E. Ristoff, A. Larsson, M. Duran, J. A. C. van Lier, L. Dorland, R. Berger, T. J. de Koning

Mitochondrial respiratory chain disease presenting as progressive bulbar paralysis of childhood

A. B. C. Roeleveld-Versteegh, K. P. J. Braun, J. A. M. Smeitink, L. Dorland, T. J. de Koning

Fatal presentation of ornithine transcarbamylase deficiency in a 62-year-old man and family studies

T. Rohininath, D. J. Costello, T. Lynch, A. Monavari, M. Tuchman, E. P. Treacy

Carrier screening for Canavan disease in Australia

V. M. Howell, A. L. Proos, D. LaRue, C. H. Jensen, F. Beach, L. Burnett

Sedation with 4-hydroxybutyric acid: A potential pitfall in the diagnosis of SSADH deficiency

N. I. Wolf, D. Haas, G. F. Hoffmann, C. Jakobs, G. S. Salomons, R. A. Wevers, U. F. Engelke, D. Rating

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine